|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of InMed Pharmaceuticals (NASDAQ: INM) through any online brokerage.
There are no as such competitors for InMed Pharmaceuticals.
The latest price target for InMed Pharmaceuticals (NASDAQ: INM) was reported by HC Wainwright & Co. on November 29, 2021. The analyst firm set a price target for 6.00 expecting INM to rise to within 12 months (a possible 308.16% upside). 2 analyst firms have reported ratings in the last year.
The stock price for InMed Pharmaceuticals (NASDAQ: INM) is $1.47 last updated Fri Dec 03 2021 21:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for InMed Pharmaceuticals.
InMed Pharmaceuticals’s $Q2 earnings are confirmed for after-market on February 10, 2022.
There is no upcoming split for InMed Pharmaceuticals.
InMed Pharmaceuticals is in the sector and industry. They are listed on the NASDAQ.